The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 11, 2025

Filed:

Apr. 04, 2023
Applicants:

Sumitomo Pharma Co., Ltd., Osaka, JP;

Healios K.k., Tokyo, JP;

Inventors:

Satoshi Ando, Osaka, JP;

Takao Kuroda, Osaka, JP;

Assignees:

SUMITOMO PHARMA CO., LTD., Osaka, JP;

HEALIOS K.K., Tokyo, JP;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 35/50 (2015.01); A61K 35/30 (2015.01); A61K 35/545 (2015.01); A61L 27/00 (2006.01); C12N 5/079 (2010.01); C12Q 1/02 (2006.01); G01N 33/50 (2006.01);
U.S. Cl.
CPC ...
C12N 5/0621 (2013.01); A61K 35/30 (2013.01); A61K 35/545 (2013.01); A61L 27/00 (2013.01); C12Q 1/02 (2013.01); G01N 33/5014 (2013.01); G01N 33/5044 (2013.01); C12N 2500/90 (2013.01); C12N 2501/115 (2013.01); C12N 2501/999 (2013.01); C12N 2506/03 (2013.01);
Abstract

The invention provides a method for producing a retinal pigment epithelial cell by (1) maintaining and/or expanding human pluripotent stem cells comprising culturing the human pluripotent stem cells in the absence of a feeder cell in a medium comprising a factor for maintaining an undifferentiated state, (2) a first step for culturing the maintained and/or expanded human pluripotent stem cells in a medium comprising a MEK inhibitor in the absence of feeder cells for a period of not less than 2 days and not more than 30 days, wherein the culture condition in the first step is a condition sufficient for inducing gene expression of at least one eye field transcription factor, and (3) a second step for culturing the cells obtained in the first step in the presence of a Nodal signal transduction pathway inhibitor and/or a Wnt signal transduction pathway inhibitor to form a retinal pigment epithelial cell.


Find Patent Forward Citations

Loading…